189 related articles for article (PubMed ID: 28858837)
21. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
22. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
Lin M; Teng L; Wang Y; Zhang J; Sun X
Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
[TBL] [Abstract][Full Text] [Related]
23. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
24. In Vitro Cytotoxicity and Bioavailability of Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin.
Vijayakumar A; Baskaran R; Baek JH; Sundaramoorthy P; Yoo BK
AAPS PharmSciTech; 2019 Jan; 20(2):88. PubMed ID: 30675630
[TBL] [Abstract][Full Text] [Related]
25. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.
Wang L; Luo Q; Lin T; Li R; Zhu T; Zhou K; Ji Z; Song J; Jia B; Zhang C; Chen W; Zhu G
Drug Dev Ind Pharm; 2015; 41(7):1204-12. PubMed ID: 25010850
[TBL] [Abstract][Full Text] [Related]
26. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin.
Bapat P; Ghadi R; Chaudhari D; Katiyar SS; Jain S
Int J Pharm; 2019 Apr; 560():219-227. PubMed ID: 30776407
[TBL] [Abstract][Full Text] [Related]
27. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of pharmacokinetics of curcumin in rats administered with two kinds of polymeric micelles].
Zhang D; Xu Q; Liu K; Xu H
Zhongguo Zhong Yao Za Zhi; 2016 Oct; 41(19):3668-3673. PubMed ID: 28925166
[TBL] [Abstract][Full Text] [Related]
29. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
30. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
Li F; Weng Y; Wang L; He H; Yang J; Tang X
Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
[TBL] [Abstract][Full Text] [Related]
31. Thermosensitive in situ nanogel as ophthalmic delivery system of curcumin: development, characterization, in vitro permeation and in vivo pharmacokinetic studies.
Liu R; Sun L; Fang S; Wang S; Chen J; Xiao X; Liu C
Pharm Dev Technol; 2016 Aug; 21(5):576-82. PubMed ID: 26024239
[TBL] [Abstract][Full Text] [Related]
32. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation.
Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G
Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497
[TBL] [Abstract][Full Text] [Related]
33. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA.
Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J
Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444
[TBL] [Abstract][Full Text] [Related]
34. Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin.
Han Y; Zhang Y; Li D; Chen Y; Sun J; Kong F
Int J Nanomedicine; 2014; 9():4107-16. PubMed ID: 25187713
[TBL] [Abstract][Full Text] [Related]
35. PEGylated long circulating nanostructured lipid carriers for Amoitone B: preparation, cytotoxicity and intracellular uptake.
Luan J; Yang X; Chu L; Xi Y; Zhai G
J Colloid Interface Sci; 2014 Aug; 428():49-56. PubMed ID: 24910034
[TBL] [Abstract][Full Text] [Related]
36. UV Spectrophotometric method for characterization of curcumin loaded nanostructured lipid nanocarriers in simulated conditions: Method development, in-vitro and ex-vivo applications in topical delivery.
Rapalli VK; Kaul V; Gorantla S; Waghule T; Dubey SK; Pandey MM; Singhvi G
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Jan; 224():117392. PubMed ID: 31330421
[TBL] [Abstract][Full Text] [Related]
37. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy.
Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F
Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648
[TBL] [Abstract][Full Text] [Related]
38. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
[TBL] [Abstract][Full Text] [Related]
39. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
40. Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect.
Xu M; Li G; Zhang H; Chen X; Li Y; Yao Q; Xie M
Drug Deliv; 2020 Dec; 27(1):983-995. PubMed ID: 32611218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
